WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
about
Allosterically targeting EGFR drug-resistance gatekeeper mutationsGenomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma.The role of histone lysine methyltransferase NSD3 in cancerDevelopment of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
P2860
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@en
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@nl
type
label
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@en
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@nl
prefLabel
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@en
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@nl
P2093
P2860
P356
P1433
P1476
WHSC1L1-mediated EGFR mono-met ...... EGFR in head and neck cancer.
@en
P2093
Jae-Hyun Park
Kazuma Kiyotani
Makda Zewde
Mark Lingen
Naoshi Dohmae
Ryuji Hamamoto
Takehiro Suzuki
Theodore Vougiouklakis
Vassiliki Saloura
Xiaolan Deng
P2860
P2888
P356
10.1038/SREP40664
P407
P577
2017-01-19T00:00:00Z